ArticleThe Journal of clinical investigation2025
NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistance.
Narsimha Mamidi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it